Perrigo Company Profile
What is the competitive landscape for PERRIGO
PERRIGO has one hundred and thirteen approved drugs.
There are three tentative approvals on PERRIGO drugs.
Summary for Perrigo
| US Patents: | 0 |
| Tradenames: | 66 |
| Ingredients: | 56 |
| NDAs: | 113 |
| Patent Litigation for Perrigo: | See patent lawsuits for Perrigo |
| PTAB Cases with Perrigo as petitioner: | See PTAB cases with Perrigo as petitioner |
Drugs and US Patents for Perrigo
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Perrigo R And D | ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED RELEASE;ORAL | 207193-001 | Aug 18, 2017 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Perrigo | ISONIAZID | isoniazid | TABLET;ORAL | 083060-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Perrigo Pharma Intl | DICLOFENAC SODIUM | diclofenac sodium | GEL;TOPICAL | 211253-001 | May 16, 2019 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Perrigo R And D | CETIRIZINE HYDROCHLORIDE HIVES | cetirizine hydrochloride | TABLET;ORAL | 078336-004 | Dec 27, 2007 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Perrigo New York | HYDROCORTISONE | hydrocortisone | LOTION;TOPICAL | 085663-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Perrigo New York | PERMETHRIN | permethrin | LOTION;TOPICAL | 076090-001 | Dec 20, 2001 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
